These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 25169642)

  • 41. Efficacy of escitalopram in the treatment of social anxiety disorder: A meta-analysis versus placebo.
    Baldwin DS; Asakura S; Koyama T; Hayano T; Hagino A; Reines E; Larsen K
    Eur Neuropsychopharmacol; 2016 Jun; 26(6):1062-9. PubMed ID: 26971233
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dissociable effects of acute SSRI (escitalopram) on executive, learning and emotional functions in healthy humans.
    Skandali N; Rowe JB; Voon V; Deakin JB; Cardinal RN; Cormack F; Passamonti L; Bevan-Jones WR; Regenthal R; Chamberlain SR; Robbins TW; Sahakian BJ
    Neuropsychopharmacology; 2018 Dec; 43(13):2645-2651. PubMed ID: 30305705
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Single dose testosterone administration alleviates gaze avoidance in women with Social Anxiety Disorder.
    Enter D; Terburg D; Harrewijn A; Spinhoven P; Roelofs K
    Psychoneuroendocrinology; 2016 Jan; 63():26-33. PubMed ID: 26402923
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Actual driving performance and psychomotor function in healthy subjects after acute and subchronic treatment with escitalopram, mirtazapine, and placebo: a crossover trial.
    Wingen M; Bothmer J; Langer S; Ramaekers JG
    J Clin Psychiatry; 2005 Apr; 66(4):436-43. PubMed ID: 15816785
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Facilitation of emotion regulation with a single dose of escitalopram: A randomized fMRI study.
    Outhred T; Das P; Felmingham KL; Bryant RA; Nathan PJ; Malhi GS; Kemp AH
    Psychiatry Res; 2015 Sep; 233(3):451-7. PubMed ID: 26210693
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serotonin and the neural processing of facial emotions in adults with autism: an fMRI study using acute tryptophan depletion.
    Daly EM; Deeley Q; Ecker C; Craig M; Hallahan B; Murphy C; Johnston P; Spain D; Gillan N; Brammer M; Giampietro V; Lamar M; Page L; Toal F; Cleare A; Surguladze S; Murphy DG
    Arch Gen Psychiatry; 2012 Oct; 69(10):1003-13. PubMed ID: 22638012
    [TBL] [Abstract][Full Text] [Related]  

  • 47. SSRI enhances sensitivity to background outcomes and modulates response rates: A randomized double blind study of instrumental action and depression.
    Msetfi RM; Kumar P; Harmer CJ; Murphy RA
    Neurobiol Learn Mem; 2016 May; 131():76-82. PubMed ID: 26976091
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of 5-HT1a and 5-HT2a receptors in attention and motor control: a mechanistic study in healthy volunteers.
    Wingen M; Kuypers KP; Ramaekers JG
    Psychopharmacology (Berl); 2007 Feb; 190(3):391-400. PubMed ID: 17124621
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The selective serotonin re-uptake inhibitor escitalopram modulates the panic response to cholecystokinin tetrapeptide in healthy men depending on 5-HTTLPR genotype.
    Kellner M; Muhtz C; Demiralay C; Husemann J; Koelsch W; Yassouridis A; Wiedemann K
    J Psychiatr Res; 2009 Mar; 43(6):642-8. PubMed ID: 18930474
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Attachment anxiety moderates the effect of oxytocin on negative emotion recognition: Evidence from eye-movement data.
    Wang T; Tang Q; Wu X; Chen X
    Pharmacol Biochem Behav; 2020 Nov; 198():173015. PubMed ID: 32835786
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oxytocin Reduces Face Processing Time but Leaves Recognition Accuracy and Eye-Gaze Unaffected.
    Hubble K; Daughters K; Manstead AS; Rees A; Thapar A; van Goozen SH
    J Int Neuropsychol Soc; 2017 Jan; 23(1):23-33. PubMed ID: 27866504
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of serotonergic and noradrenergic antidepressants on face emotion processing in depressed patients.
    Tranter R; Bell D; Gutting P; Harmer C; Healy D; Anderson IM
    J Affect Disord; 2009 Nov; 118(1-3):87-93. PubMed ID: 19250683
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Escitalopram 10 mg/day is effective and well tolerated in a placebo-controlled study in depression in primary care.
    Wade A; Michael Lemming O; Bang Hedegaard K
    Int Clin Psychopharmacol; 2002 May; 17(3):95-102. PubMed ID: 11981349
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reboxetine promotes social bonding in healthy volunteers.
    Tse WS; Bond AJ
    J Psychopharmacol; 2003 Jun; 17(2):189-95. PubMed ID: 12870566
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Early changes in emotional processing as a marker of clinical response to SSRI treatment in depression.
    Godlewska BR; Browning M; Norbury R; Cowen PJ; Harmer CJ
    Transl Psychiatry; 2016 Nov; 6(11):e957. PubMed ID: 27874847
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
    Pelissolo A
    Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ziprasidone Augmentation of Escitalopram for Major Depressive Disorder: Cardiac, Endocrine, Metabolic, and Motoric Effects in a Randomized, Double-Blind, Placebo-Controlled Study.
    Mischoulon D; Shelton RC; Baer L; Bobo WV; Curren L; Fava M; Papakostas GI
    J Clin Psychiatry; 2017 Apr; 78(4):449-455. PubMed ID: 27835715
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Emotional Tears: An Honest Signal of Trustworthiness Increasing Prosocial Behavior?
    Reed LI; Matari Y; Wu M; Janaswamy R
    Evol Psychol; 2019; 17(3):1474704919872421. PubMed ID: 31455105
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The beneficial effect of oxytocin on avoidance-related facial emotion recognition depends on early life stress experience.
    Feeser M; Fan Y; Weigand A; Hahn A; Gärtner M; Aust S; Böker H; Bajbouj M; Grimm S
    Psychopharmacology (Berl); 2014 Dec; 231(24):4735-44. PubMed ID: 24871703
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Escitalopram : a review of its use in the management of major depressive and anxiety disorders.
    Waugh J; Goa KL
    CNS Drugs; 2003; 17(5):343-62. PubMed ID: 12665392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.